Amazon Pharmacy is offering six-month prescriptions starting at $6 for medications for common ailments. This is the company’s latest effort to persuade more people to…
Posts published in “News”
California based Gilead Sciences Inc. shares, +0.13% inches 0.13% higher to $67.51 Tuesday. This proved to be an all-around mixed trading session for the stock…
Halucenex Life Sciences, a Creso Pharma (ASX: CPH) acquisition target in Canada, has increased the enrollment of phase II clinical study of the psychedelic psilocybin…
On Tuesday, Pfizer Inc. announced its FDA approval for PREVNAR 20TM, which is a Pneumococcal 20-valent Conjugate Vaccine enabling prevention of pneumonia, and invasive diseases. These…
Biogen witnessed a productive surge in shares by 38% after receiving FDA approval of the Alzheimer’s drug, considered to be a breakthrough in Alzheimer’s treatment…
Virtual Care became engaging for the health plan member in New York City during the pandemic. New York City was one of the first places…
As per the trusted sources of information, another set of investigational products has received approval from the FDA, which consists of a number of diagnostic…
As part of MorphoSys $1.7 billion acquisition of Constellation Pharmaceuticals, Royalty Pharma plc, and MorphoSys AG today announced a $2.025 billion strategic funding collaboration. This…
City of Rome Historian Mike Colangelo had a fascination with local history that led him to genealogical research. Colangelo has a camp in Boonville where…
Roivant Sciences signed a SPAC contract to go public earlier this month, but the company isn’t abandoning the SPAC route just yet. Immunovant, one of…